Loading page…
A Nigerian B2B healthtech and logistics company digitizing pharmaceutical supply for pharmacies and hospitals across Africa.
100M medicines delivered annually · 450+ employees · about 100 vehicles
The company started as healthtech without the tech: pharmacies called a number, the team scrambled to source medicines, and the software came after the operation was understood.
Fewer bars = easier, cheaper, or faster for an AI-assisted solo builder. Editorial judgments based on the case details.
Samuel Okwuada combined pharmacy experience, a software studio and pharmaceutical supplier relationships to build Remedial Health in Nigeria. The trigger was the 2020 Lagos lockdown: pharmacies and hospitals could operate, but the open markets where they bought medicines were closed. Pharmacies began calling the number on his medicine packaging, asking for small quantities that his import business had not been set up to sell. Remedial's first version had no software. Customers called or used WhatsApp, and the team manually sourced and delivered products. The technology followed the operation: customer, sales-agent and driver apps plus an ERP for procurement, warehouse inventory, pick-and-pack, barcodes and scanning. The company now has more than 450 people, about 100 vehicles on the road, three warehouses and a stated throughput of 100 million medicines annually. The interview describes more than $50 million raised and a business that also has to own pharmaceutical logistics because dedicated cold-chain infrastructure is scarce.
Remedial's first customers were pharmacies and hospitals already experiencing an urgent supply problem. During the Lagos lockdown, the markets they normally used were closed, but healthcare businesses still had to serve patients.
The quick-reference card — acquisition channels, replication playbook, risks & traps, and our verdict — is members-only.
Join the Unicorn Club — $5/moCancel anytime, in one clickPaste into Claude Code / Codex and get a working version of this product end-to-end.
Two production-grade prompts per idea — a full build spec and an SEO growth plan — plus 10 tailored build specs a week. Members only.
Join the Unicorn Club — $5/moCancel anytime, in one clickEvery claim traces back to a listed source — open any of them and check the number yourself.
Data credibility: The episode's host and opening description report that Remedial Health has raised over $50 million, employs more than 450 people, operates about 100 vehicles and delivers 100 million medicines annually to thousands of pharmacies and hospitals. Samuel Okwuada personally confirms the team, vehicle and operating complexity, and explains the manual-to-software evolution. These scale figures are creator/interviewer-reported and founder-accepted in conversation; the transcript provides no audited revenue, margin, customer count reconciliation or independent verification.
The first Remedial transaction arrived as a manual B2B order: a pharmacy or hospital contacted the team by phone or WhatsApp, requested a medicine, and the team scrambled to source and deliver it. There was no customer app, no driver app and no ERP at the beginning.
The flywheel is operational reliability. More pharmacy orders create better demand data, which improves procurement and inventory placement; better availability makes pharmacies order again; repeat orders justify warehouses, drivers and software.
Samuel's hardest stretch came before the operating model was proven and again whenever scale exposed a new failure. Pharmaceutical importation took roughly three years of registration and regulatory hurdles, while capital was tied up in products that could not move.
Remedial Health is a B2B pharmaceutical supply and logistics system. Pharmacies and hospitals order medicines, the company procures and stores authentic stock, and its teams deliver through a controlled network. The technology includes a customer app, an agent app for salespeople, a driver app and an ERP that manages procurement, warehouse locations, pick-and-pack, barcodes and scanning. The first version was deliberately non-technical: call or WhatsApp the team and receive a manually fulfilled order. The operating model now contains a logistics company inside the healthtech company because the market lacks dedicated pharmaceutical logistics and medicines can lose potency through poor handling. Our read: this is a hard but defensible category when product integrity, local availability and delivery speed matter more than a lightweight marketplace experience. The company is still B2B, which keeps the buyer relationship concentrated but makes enterprise procurement, working capital and regulation central to the design.
Remedial sells pharmaceutical products and related supply-chain service to pharmacies and hospitals, with financing and inventory management described as part of the offering. The transcript provides scale figures rather than a revenue figure: more than $50 million raised, 100 million medicines delivered annually, 450-plus employees and about 100 vehicles. The core economic question is contribution margin per fulfilled order after procurement, warehousing, expiry, labor, vehicle cost, route loss and financing. A large order can be dangerous if it concentrates inventory or delivery risk; the truck carrying 50 million naira of orders shows why revenue volume is not the same as healthy cash flow. The model becomes stronger when recurring pharmacy demand improves purchasing terms and warehouse turns while delivery remains reliable. A founder building a smaller version should price by product margin and service cost, not by software seat. Growth must eventually be profitable and sustainable as the company expands into more countries.
The stack is operational software wrapped around physical infrastructure: three mobile apps, an ERP, warehouses, inventory processes, barcodes, scanning, vehicles and teams for procurement, operations, logistics and sales. The founder says the business has more than 450 employees and about 100 vehicles, with warehouses in Lagos, Asaba and Kano. Costs therefore include working capital for medicine inventory, warehouse labor, drivers, maintenance, fuel, route security, compliance, expiry and damage. The transcript gives no margin or cost breakdown, so any claim about profitability would be false precision. The important design choice is ownership. In Nigeria, the company owns logistics because poor roads, limited pharmaceutical logistics providers and handling conditions can damage product quality. Our read: build the operational data layer first, then use it to improve demand forecasting and route density. The software is valuable because it coordinates a difficult system; it does not remove the physical system.
Copy the founder's sequence: use a local supply-chain problem, serve it manually, observe the repeated work and only then build the platform. Copy the choice to focus on a painful old industry where investors can understand an equivalent model in developed markets. Change the scale ambition for an early operator. Do not begin with 450 employees, 100 vehicles and three warehouses; begin with one city, a narrow product set, a small delivery radius and a clear service promise. Change the financing model too. Track cash conversion and expiry before accepting a large government or hospital order that can overwhelm logistics. Build a quality system for authenticity, temperature, humidity and batch traceability from the first day. The strongest transferable idea is that local infrastructure can become the moat when it is required to deliver the core product. The hardest-to-copy part is not the app; it is the verified operating network.
This business carries unusually high execution risk. Medicines are regulated, expire and can be damaged by heat, humidity or rough handling. A failed route can create financial loss and a patient-safety problem at the same time. Working capital is another threat: inventory and large orders consume cash before customers pay, while a truck can carry 50 million naira of product and still be lost to a bad road. The company also faces regulatory raids, law-enforcement extortion and security risks on routes. Scale adds people-management complexity across drivers, warehouse teams, procurement, sales and engineers. Competitive risk is lower than in generic B2B software, but a better-funded distributor or a regulatory change can still compress margins. Finally, raising more than $50 million can create pressure to grow before unit economics are durable. The business survives by making authenticity, fill rate, delivery reliability and cash discipline non-negotiable.
The four founder playbooks — first customers, first dollar, the flywheel, the silent stretch — are in the Unicorn Club, on this idea and on all 1,435 others. The story, the numbers, the sources and every later section stay open to everyone.
Join the Unicorn Club — $5/moCancel anytime, in one click